LIFECORE BIOMEDICAL, INC. Decrease in Unrecognized Tax Benefits is Reasonably Possible
LIFECORE BIOMEDICAL, INC. (LFCR) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $32.00 thousand as of 2019-05-26, per its 10-K filed 2019-08-01.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2019-08-01
- 2019-05-26: Decrease in Unrecognized Tax Benefits is Reasonably Possible $32.00K.
- 2018-05-27: Decrease in Unrecognized Tax Benefits is Reasonably Possible $25.00K.
- 2017-08-27: Decrease in Unrecognized Tax Benefits is Reasonably Possible $215.00K.
- 2017-05-28: Decrease in Unrecognized Tax Benefits is Reasonably Possible $215.00K.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible |
|---|---|
| 2019-05-26 | $32.00K 10-K · filed 2019-08-01 |
| 2018-05-27 | $25.00K 10-K · filed 2018-08-09 |
| 2017-08-27 | $215.00K 10-Q · filed 2017-09-28 |
| 2017-05-28 | $215.00K 10-K/A · filed 2018-03-15 |
| 2017-02-26 | $300.00K 10-Q · filed 2017-04-07 |
| 2016-11-27 | $300.00K 10-Q · filed 2017-01-05 |
| 2016-08-28 | $300.00K 10-Q · filed 2016-09-29 |
| 2016-05-29 | $300.00K 10-K · filed 2016-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |